AAAAAA

   
Results: 1-8 |
Results: 8
ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) FOR EARLY BREAST-CANCER - 13 YEARS UPDATE OF A MULTICENTER RANDOMIZED TRIAL
Authors: FOCAN C BEAUDUIN M SALAMON E DEGREVE J DEWASCH G LOBELLE JP MAJOIS F TAGNON A TYTGAT J VANBELLE S VANDERVELLEN R VINDEVOGHEL A
Citation: C. Focan et al., ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) FOR EARLY BREAST-CANCER - 13 YEARS UPDATE OF A MULTICENTER RANDOMIZED TRIAL, European journal of cancer, 34, 1998, pp. 102-102
CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY
Authors: GOEDHALS L HERON JF KLEISBAUER JP PAGANI O SESSA C GIGER K CAVALLI F LUDWIG C AAPRO M BLEIBERG H DEWASH G DICATO M TAGNON A VANSTRAELEN D VINDEVOGHEL A ABRATT R FALKSON G BARLEY V CARMICHAEL J COLEMAN R DAVIDSON N GRIEVE R HARPER P ROBERTS J RUSTIN G NAMAN H SCHNEIDER M NOBLE A NETTER P CUPISSOL D BALMES P CALS L KHAYAT D CATIMEL G DUTIN JP BOUFETTE P ADENIS L MISSET J COLLERY P NOUVET G CHAVAILLON JM BLANCHON F POIRIER R ARNAUD A LECAER H CARLES P MUIR J BONNAUD F MARQUESTE L CLAVIER J GUERIN J TAYTARD A KEIZER H NORTIER J SLEE P WILS J RODENBURG C BURGHOUTS J DEWIT R GARCIAGIRON C JIMENEZLACAVE A CRUZHERNANDEZ J MASSUTISUREDA B HANS K FUCHS R KRIEGMAIR M SCHULLER J LAHOUSEN M PANNUTI F MONFARDINI S NILSSON S
Citation: L. Goedhals et al., CONTROL OF DELAYED NAUSEA AND VOMITING WITH GRANISETRON PLUS DEXAMETHASONE OR DEXAMETHASONE ALONE IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY - A DOUBLE-BLIND, PLACEBO-CONTROLLED, COMPARATIVE-STUDY, Annals of oncology, 9(6), 1998, pp. 661-666
A PHASE-II STUDY TESTING WEEKLY PLATINUM DERIVATIVE COMBINATION CHEMOTHERAPY AS 2ND-LINE TREATMENT IN PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER
Authors: SCULIER JP THIRIAUX J BUREAU G LAFITTE JJ RECLOUX P BROHEE D BERCHIER MC SERGYSELS R MOMMEN P PAESMANS M KLASTERSKY J LECOMTE J VANSCHAARDENBURG C RICHARD V DIANA D FORTIN F TAGNON A KUSTNER U
Citation: Jp. Sculier et al., A PHASE-II STUDY TESTING WEEKLY PLATINUM DERIVATIVE COMBINATION CHEMOTHERAPY AS 2ND-LINE TREATMENT IN PATIENTS WITH ADVANCED SMALL-CELL LUNG-CANCER, International journal of oncology, 6(2), 1995, pp. 425-429
UNEXPECTED OPPOSITE AGE-RELATED EFFECT OF ADJUVANT HIGH-DOSE PROGESTERONE ACETATE (HD-MPA) FOR NODE-POSITIVE (NP) EARLY BREAST-CANCER - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL
Authors: FOCAN C BEAUDUIN M SALAMON E DEGREVE J DEWASCH G LOBELLE JP MAJOIS F TAGNON A TYTGAT J VANBELLE S VANDERVELLEN R VINDEVOGHEL A
Citation: C. Focan et al., UNEXPECTED OPPOSITE AGE-RELATED EFFECT OF ADJUVANT HIGH-DOSE PROGESTERONE ACETATE (HD-MPA) FOR NODE-POSITIVE (NP) EARLY BREAST-CANCER - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL, European journal of cancer, 31A, 1995, pp. 46-46
IMPROVEMENT OF PROGNOSIS IRRESPECTIVE OF AGE IN EARLY NODE-NEGATIVE EARLY BREAST-CANCER BY ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL
Authors: FOCAN C BEAUDUIN M SALAMON E DEGREVE J DEWASCH G LOBELLE JP MAJOIS F TAGNON A TYTGAT J VANBELLE S VANDERVELLEN R VINDEVOGHEL A
Citation: C. Focan et al., IMPROVEMENT OF PROGNOSIS IRRESPECTIVE OF AGE IN EARLY NODE-NEGATIVE EARLY BREAST-CANCER BY ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL, European journal of cancer, 31A, 1995, pp. 56-56
A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN
Authors: GOEDHALS L JORDAAN JP KAYE SB ARMAND JP VEENHOF CHN FALKSON G SOUKOP M SCHNEIDER M OBERLING F BUI BN ROCHE H ADENIS L CATY A BLIJHAM GH DEWEWEIRE A COIFFIER B SOTTO JJ VANHEUKELOM LS TAGNON A SLEE PHTJ KROEKS MVAM RAVEZ P CUPISSOL D KEIZER HJ BRUNNER K CALVERT AH YERNAULT JC LIBERT P BROHEE D
Citation: L. Goedhals et al., A DOSE-FINDING STUDY OF GRANISETRON, A NOVEL ANTIEMETIC, IN PATIENTS RECEIVING HIGH-DOSE CISPLATIN, Supportive care in cancer, 2(3), 1994, pp. 177-183
A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
Authors: KLASTERSKY J SCULIER JP RIES F DABOUIS G LIBERT P SCHMERBER J THIRIAUX J BERCHIER MC BUREAU G VANCUTSEM O TAGNON A SERGYSELS R MOMMEN P PAESMANS M
Citation: J. Klastersky et al., A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Annals of oncology, 5(7), 1994, pp. 641-643
A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER
Authors: KLASTERSKY J SCULIER JP RIES F DABOUIS G LIBERT P SCHMERBER J THIRIAUX J BERCHIER MC BUREAU G VANCUTSEM O TAGNON A SERGYSELS R MOMMEN P PAESMANS M
Citation: J. Klastersky et al., A 4-DRUG COMBINATION CHEMOTHERAPY WITH CISPLATIN, MITOMYCIN, VINDESINE AND 5-FLUOROURACIL - A REGIMEN ASSOCIATED WITH MAJOR TOXICITY IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER, Lung cancer, 11(5-6), 1994, pp. 373-384
Risultati: 1-8 |